A clinical trial using focused ultrasound to treat Alzheimer’s disease has shown promising results, marking a potential new direction in treating this debilitating condition.
The Food and Drug Administration (FDA) continues to oversee the approval process for new products, drugs, therapies, and treatments, with updates on applications, safety alerts, and more.
Rise Therapeutics is currently conducting a Phase 1 clinical trial for R-3750, an oral immune therapy, in patients with mild to moderate ulcerative colitis.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.